Champalimaud Foundation
Marta Estrada is a seasoned researcher specializing in cancer biology and personalized medicine, currently leading a phase IV clinical trial on the zAvatar-test for relapsed ovarian cancer and metastatic breast cancer at the Champalimaud Foundation. With a strong background in the development of innovative cancer treatments, Marta has contributed to various projects aimed at enhancing patient-specific therapy models, including roles as co-PI on significant research initiatives for ovarian cancer avatars and AI-empowered analyses. Previous experience spans several research positions, including a PhD at Faculdade de Ciências e Tecnologia da Universidade NOVA de Lisboa and work at institutions such as iBET and EPFL, focusing on drug efficacy testing models and cancer cell cultures. Educational qualifications include a PhD in Biological Engineering and a Master's in Biotechnology, both from Universidade NOVA de Lisboa.